Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide

    Vesugen vs GHK-Cu

    Side-by-side comparison of Vesugen and GHK-Cu: mechanism, half-life, dose range, safety profile, and vendor pricing.

    Vesugen from $49.99
    GHK-Cu from $34.99

    Price snapshot

    Vesugen

    Current low
    $49.99
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    GHK-Cu

    Current low
    $34.99
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    Vesugen

    Vesugen is a short synthetic peptide developed within Vladimir Khavinson's laboratory at the Saint Petersburg Institute of Bioregulation and Gerontology and marketed in Russia as an oral capsule for vascular and…

    Lowest listed price: $49.99 across 1 listing

    Full Vesugen profile

    GHK-Cu

    GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a molecule Pickart and Thaler first pulled out of human plasma in 1973. The free peptide (GHK, C14H24N6O4) weighs about 340.4 Da; bind it 1:1…

    Lowest listed price: $34.99 across 7 listings

    Full GHK-Cu profile

    Side-by-side comparison

    Attribute Vesugen GHK-Cu
    Category Recovery Skin, Hair & Aesthetics
    Research Stage Preclinical Approved/marketed as a topical cosmetic ingredient (Copper tripeptide-1) with supporting small human studies. Injectable use is preclinical/off-label, research-use-only, with no human clinical trials.
    Mechanism of Action Vesugen's proposed mechanism follows the three-stage Khavinson short-peptide framework. At the pharmacokinetic level, oral dosing is claimed to produce sufficient intact peptide absorption to deliver bioactive quantities to target tissues. Mechanistic work… GHK-Cu works mostly as a copper shuttle and a signaling peptide. It binds Cu(II) with high affinity (log K around 16.4, close to albumin's 16.2) and can supply or regulate copper for copper-dependent enzymes like SOD1, lysyl oxidase, cytochrome c oxidase, and…
    Half-Life Not established in humans. As a short tripeptide, KED is expected to be rapidly hydrolyzed in plasma, with an anticipated half-life on the order of minutes; no formal pharmacokinetic study of Vesugen has been published. ~30-60 min (plasma; approximate legacy figure, no robust modern human PK study)
    Typical Dose Range 20 mg oral capsule 1-2 daily for 10-day cycles (60-90 day washout) 200-500 mcg SC daily (community/RUO; no clinically established injectable dose)
    Dosing Frequency 1-2 capsules daily during the 10-day cycle Once daily subcutaneous; some run 5 days on / 2 days off. Topical: 1-2x daily to cleansed skin.
    Administration — Subcutaneous, Topical
    Side Effects Published Khavinson-group observations describe Vesugen as well tolerated at the recommended oral dose of 1 to 2 capsules daily during a 10-day cycle. Specific adverse events noted include occasional mild gastrointestinal discomfort (nausea, loose stools)… Topical GHK-Cu is generally well tolerated; higher-concentration formulations (4-5%) raise the odds of irritation, redness, or stinging. Injectable use has no safety data from controlled trials; the main theoretical concern is copper accumulation with repeated…
    Molecular Weight 390.39 g/mol Free peptide (GHK): 340.38 Da (C14H24N6O4). Copper complex (GHK-Cu): 401.9 Da (C14H22CuN6O4, neutral 1:1 Cu(II) complex).
    Common Vial Sizes — 50 mg, 100 mg

    Price tracking

    Tracking Vesugen prices since October 27, 2026. Trend chart unlocks once we have price snapshots from more than one day.

    Price History

    4 data points
    • OF
    • BM
    • Half Nattys
    • BHG Labs

    Vesugen: potential benefits

    • Vascular health support
    • Blood vessel integrity maintenance
    • Endothelial function optimization
    • Cardiovascular anti-aging

    GHK-Cu: potential benefits

    • Stimulates type I collagen synthesis in human fibroblasts at low nanomolar-to-picomolar concentrations (PMID: 3169264)
    • Increases glycosaminoglycans (dermatan/chondroitin sulfate) and upregulates decorin in wound models (PMID: 11121126)
    • Modulates matrix metalloproteinases and their inhibitors, partially correcting the MMP-9/TIMP-1 imbalance in a smoke-induced emphysema model (PMID: 35936787)
    • Drives tissue remodeling and chemoattracts macrophages, mast cells, and capillary cells to injury sites (PMID: 18644225)
    • Modulates expression of ~4,000+ human genes via the Broad Institute Connectivity Map, including DNA-repair and antioxidant genes (PMID: 25302294)
    • Increases stemness and proliferative potential of epidermal basal cells and keratinocytes (PMID: 23019153)
    • Acts as an antioxidant and anti-inflammatory copper regulator in the context of aging (PMID: 22666519)
    • Broad skin-regeneration effects on collagen, proteoglycans, MMPs, and immune/endothelial cell recruitment (PMID: 26236730)

    Frequently asked

    What's the difference between Vesugen and GHK-Cu?

    Vesugen is a recovery that vesugen's proposed mechanism follows the three-stage khavinson short-peptide framework. at the pharmacokinetic level, oral dosing is claimed to produce sufficient intact peptide…. GHK-Cu is a skin, hair & aesthetics that ghk-cu works mostly as a copper shuttle and a signaling peptide. it binds cu(ii) with high affinity (log k around 16.4, close to albumin's 16.2) and can supply or regulate copper…. The two differ in mechanism, half-life (Not established in humans. As a short tripeptide, KED is expected to be rapidly hydrolyzed in plasma, with an anticipated half-life on the order of minutes; no formal pharmacokinetic study of Vesugen has been published. vs ~30-60 min (plasma; approximate legacy figure, no robust modern human PK study)), and typical dose range.

    Which has the longer half-life, Vesugen or GHK-Cu?

    Vesugen has a half-life of Not established in humans. As a short tripeptide, KED is expected to be rapidly hydrolyzed in plasma, with an anticipated half-life on the order of minutes; no formal pharmacokinetic study of Vesugen has been published.. GHK-Cu has a half-life of ~30-60 min (plasma; approximate legacy figure, no robust modern human PK study). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.

    Which is cheaper, Vesugen or GHK-Cu?

    Lowest listed price on BodyHackGuide: Vesugen from $49.99, GHK-Cu from $34.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.

    Can you stack Vesugen and GHK-Cu?

    Stacking depends on mechanism overlap, safety profile, and goals. Vesugen and GHK-Cu should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.

    See current vendor prices

    Listings from the vendors we track. Prices change often, so check the vendor before you buy.

    Vesugen prices GHK-Cu prices Compare all compounds

    Before you buy Vesugen or GHK-Cu

    Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.

    View Vendor Scorecard

    Related comparisons

    GHK CU vs AHK CU

    Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.